Global Smart Diabetes Management Market Size, Status and Forecast 2019-2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Smart Diabetes Management Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Type 1 Diabetes
- 1.4.3 Type 2 Diabetes
- 1.5 Market by Application
- 1.5.1 Global Smart Diabetes Management Market Share by Application (2019-2025)
- 1.5.2 Hospital
- 1.5.3 Specialty Diabetes Clinics
- 1.5.4 Home
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Smart Diabetes Management Market Size
- 2.2 Smart Diabetes Management Growth Trends by Regions
- 2.2.1 Smart Diabetes Management Market Size by Regions (2019-2025)
- 2.2.2 Smart Diabetes Management Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Smart Diabetes Management Market Size by by Players
- 3.1.1 Global Smart Diabetes Management Revenue by by Players (2014-2019)
- 3.1.2 Global Smart Diabetes Management Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Smart Diabetes Management Market Concentration Ratio (CR5 and HHI)
- 3.2 Smart Diabetes Management Key Players Head office and Area Served
- 3.3 Key Players Smart Diabetes Management Product/Solution/Service
- 3.4 Date of Enter into Smart Diabetes Management Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Smart Diabetes Management Market Size by Type (2014-2019)
- 4.2 Global Smart Diabetes Management Market Size by Application (2014-2019)
5 North America
- 5.1 North America Smart Diabetes Management Market Size (2014-2019)
- 5.2 Smart Diabetes Management Key Players in North America
- 5.3 North America Smart Diabetes Management Market Size by Type
- 5.4 North America Smart Diabetes Management Market Size by Application
6 Europe
- 6.1 Europe Smart Diabetes Management Market Size (2014-2019)
- 6.2 Smart Diabetes Management Key Players in Europe
- 6.3 Europe Smart Diabetes Management Market Size by Type
- 6.4 Europe Smart Diabetes Management Market Size by Application
7 China
- 7.1 China Smart Diabetes Management Market Size (2014-2019)
- 7.2 Smart Diabetes Management Key Players in China
- 7.3 China Smart Diabetes Management Market Size by Type
- 7.4 China Smart Diabetes Management Market Size by Application
8 Japan
- 8.1 Japan Smart Diabetes Management Market Size (2014-2019)
- 8.2 Smart Diabetes Management Key Players in Japan
- 8.3 Japan Smart Diabetes Management Market Size by Type
- 8.4 Japan Smart Diabetes Management Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Smart Diabetes Management Market Size (2014-2019)
- 9.2 Smart Diabetes Management Key Players in Southeast Asia
- 9.3 Southeast Asia Smart Diabetes Management Market Size by Type
- 9.4 Southeast Asia Smart Diabetes Management Market Size by Application
10 India
- 10.1 India Smart Diabetes Management Market Size (2014-2019)
- 10.2 Smart Diabetes Management Key Players in India
- 10.3 India Smart Diabetes Management Market Size by Type
- 10.4 India Smart Diabetes Management Market Size by Application
11 Central & South America
- 11.1 Central & South America Smart Diabetes Management Market Size (2014-2019)
- 11.2 Smart Diabetes Management Key Players in Central & South America
- 11.3 Central & South America Smart Diabetes Management Market Size by Type
- 11.4 Central & South America Smart Diabetes Management Market Size by Application
12 International Players Profiles
- 12.1 F. Hoffmann-La Roche
- 12.1.1 F. Hoffmann-La Roche Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Smart Diabetes Management Introduction
- 12.1.4 F. Hoffmann-La Roche Revenue in Smart Diabetes Management Business (2014-2019))
- 12.1.5 F. Hoffmann-La Roche Recent Development
- 12.2 Medtronic
- 12.2.1 Medtronic Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Smart Diabetes Management Introduction
- 12.2.4 Medtronic Revenue in Smart Diabetes Management Business (2014-2019)
- 12.2.5 Medtronic Recent Development
- 12.3 Dexcom
- 12.3.1 Dexcom Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Smart Diabetes Management Introduction
- 12.3.4 Dexcom Revenue in Smart Diabetes Management Business (2014-2019)
- 12.3.5 Dexcom Recent Development
- 12.4 Insulet Corporation
- 12.4.1 Insulet Corporation Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Smart Diabetes Management Introduction
- 12.4.4 Insulet Corporation Revenue in Smart Diabetes Management Business (2014-2019)
- 12.4.5 Insulet Corporation Recent Development
- 12.5 Abbott
- 12.5.1 Abbott Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Smart Diabetes Management Introduction
- 12.5.4 Abbott Revenue in Smart Diabetes Management Business (2014-2019)
- 12.5.5 Abbott Recent Development
- 12.6 Jiangsu Delfu medical device
- 12.6.1 Jiangsu Delfu medical device Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Smart Diabetes Management Introduction
- 12.6.4 Jiangsu Delfu medical device Revenue in Smart Diabetes Management Business (2014-2019)
- 12.6.5 Jiangsu Delfu medical device Recent Development
- 12.7 DIAMESCO
- 12.7.1 DIAMESCO Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Smart Diabetes Management Introduction
- 12.7.4 DIAMESCO Revenue in Smart Diabetes Management Business (2014-2019)
- 12.7.5 DIAMESCO Recent Development
- 12.8 LifeScan
- 12.8.1 LifeScan Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Smart Diabetes Management Introduction
- 12.8.4 LifeScan Revenue in Smart Diabetes Management Business (2014-2019)
- 12.8.5 LifeScan Recent Development
- 12.9 Glooko
- 12.9.1 Glooko Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Smart Diabetes Management Introduction
- 12.9.4 Glooko Revenue in Smart Diabetes Management Business (2014-2019)
- 12.9.5 Glooko Recent Development
- 12.10 GlucoMe
- 12.10.1 GlucoMe Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Smart Diabetes Management Introduction
- 12.10.4 GlucoMe Revenue in Smart Diabetes Management Business (2014-2019)
- 12.10.5 GlucoMe Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
In 2018, the global Smart Diabetes Management market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Smart Diabetes Management status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Smart Diabetes Management development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
F. Hoffmann-La Roche
Medtronic
Dexcom
Insulet Corporation
Abbott
Jiangsu Delfu medical device
DIAMESCO
LifeScan
Glooko
GlucoMe
Market segment by Type, the product can be split into
Type 1 Diabetes
Type 2 Diabetes
Market segment by Application, split into
Hospital
Specialty Diabetes Clinics
Home
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Smart Diabetes Management status, future forecast, growth opportunity, key market and key players.
To present the Smart Diabetes Management development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Smart Diabetes Management are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.